Journal of Immunology·17 SepExacerbation of inflammatory bone loss in TET2-driven clonal hematopoiesisExperiments in miceInflammationPaper
Frontiers in Bioengineering and Biotechnology·25 AugCombined treatment of spinal cord injury using channeled Porous-GelMA scaffold loaded with genetically engineered MSCs expressing inducible ChABC and constitutive BDNFExperiments in animalsInterventionsPaper
JAMA Otolaryngology-- Head & Neck Surgery·20 AugTERT Promoter Variants, Older Age, and Prognosis in Papillary Thyroid CarcinomaStudy in peoplePopulationsPaper
Maturitas·17 AugWaist-to-height ratio time in target range and incident cardiovascular disease across glycemic status in middle-aged and older Chinese adults: A longitudinal cohort studyCohort study of 5,550 peopleCardiovascular diseasePaper
Medicine·15 AugNon-HDL-C to HDL-C ratio and risks of all-cause and cardiovascular mortality in patients with coronary heart disease and type 2 diabetes mellitus: Results from NHANES 2005 to 2018Study in peopleBiomarkersPaper
ADA Scientific Sessions 2026 Abstract·6 JunCombination Treatment of Oral Small Molecule GLP-1 Receptor Agonist Aleniglipron and Small Molecule Amylin Receptor Agonist ACCG-2671 Demonstrated Additional Weight Loss than Monotreatment in Obese NHPsExperiments in animalsInterventionsPaper
ADA Scientific Sessions 2025 Abstract·13 JunNovel Oral Small Molecule ACCG-2671—A Dual Amylin and Calcitonin Receptor Agonist Development Candidate for Obesity TherapyExperiments in animalsInterventionsPaper